Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.

Liu J, Wei XL, Huang WH, Chen CF, Bai JW, Zhang GJ.

PLoS One. 2012;7(12):e52675. doi: 10.1371/journal.pone.0052675. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/d8502df1-611d-4d4a-b697-acaee15ac8c8.

2.

Prognostic impact of Skp2 and p27 in human breast cancer.

Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R.

Breast Cancer Res Treat. 2006 Sep;99(2):185-91.

PMID:
16636894
3.

The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.

Liu X, Wang H, Ma J, Xu J, Sheng C, Yang S, Sun L, Ni Q.

Med Oncol. 2013 Dec;30(4):735. doi: 10.1007/s12032-013-0735-0.

PMID:
24277465
4.
5.

The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.

Voduc D, Nielsen TO, Cheang MC, Foulkes WD.

Hum Pathol. 2008 Oct;39(10):1431-7. doi: 10.1016/j.humpath.2008.03.004.

PMID:
18620730
6.
7.

CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?

Huang CW, Lin CY, Huang HY, Liu HW, Chen YJ, Shih DF, Chen HY, Juan CC, Ker CG, Huang CY, Li CF, Shiue YL.

Ann Surg Oncol. 2010 Mar;17(3):907-22. doi: 10.1245/s10434-009-0779-8.

PMID:
19866239
8.

SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.

Fagan-Solis KD, Pentecost BT, Gozgit JM, Bentley BA, Marconi SM, Otis CN, Anderton DL, Schneider SS, Arcaro KF.

J Cell Physiol. 2014 Sep;229(9):1160-9. doi: 10.1002/jcp.24545.

PMID:
24443386
9.
10.

Significance of skp2 expression in primary breast cancer.

Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.

Clin Cancer Res. 2006 Feb 15;12(4):1215-20.

11.

Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.

Shubbar E, Kovács A, Hajizadeh S, Parris TZ, Nemes S, Gunnarsdóttir K, Einbeigi Z, Karlsson P, Helou K.

BMC Cancer. 2013 Jan 2;13:1. doi: 10.1186/1471-2407-13-1.

12.

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z.

BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.

13.

Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.

Puzovic V, Brcic I, Ranogajec I, Jakic-Razumovic J.

Neoplasma. 2014;61(4):439-46. doi: 10.4149/neo_2014_054.

PMID:
24645837
14.

P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.

Turashvili G, McKinney SE, Goktepe O, Leung SC, Huntsman DG, Gelmon KA, Los G, Rejto PA, Aparicio SA.

Mod Pathol. 2011 Jan;24(1):64-81. doi: 10.1038/modpathol.2010.189.

15.

The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast.

Barısık NO, Keser SH, Gul AE, Sensu S, Kandemir NO, Kucuk HF, Gumus M, Karadayı N.

Med Oncol. 2011 Sep;28(3):703-8. doi: 10.1007/s12032-010-9503-6.

PMID:
20354817
16.

Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.

Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M.

Oncol Rep. 2006 Apr;15(4):765-71.

PMID:
16525656
17.

Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.

Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.

Ann Surg Oncol. 2009 Feb;16(2):395-403. doi: 10.1245/s10434-008-0236-0.

PMID:
19034576
18.

High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.

Buhmeida A, Dallol A, Merdad A, Al-Maghrabi J, Gari MA, Abu-Elmagd MM, Chaudhary AG, Abuzenadah AM, Nedjadi T, Ermiah E, Al-Thubaity F, Al-Qahtani MH.

Tumour Biol. 2014 Mar;35(3):2817-24. doi: 10.1007/s13277-013-1374-y.

PMID:
24248542
19.

Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.

Milde-Langosch K, Karn T, Müller V, Witzel I, Rody A, Schmidt M, Wirtz RM.

Breast Cancer Res Treat. 2013 Jan;137(1):57-67. doi: 10.1007/s10549-012-2296-x.

PMID:
23135572
20.

Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer.

Davidovich S, Ben-Izhak O, Shapira M, Futerman B, Hershko DD.

Breast Cancer Res. 2008;10(4):R63. doi: 10.1186/bcr2122.

Items per page

Supplemental Content

Support Center